Delta-8 THC, also known as D-8 or sometimes “Weed’s Little Brother,” is the hottest cannabinoid available to purchase—especially in states like North Carolina, where marijuana remains illegal.
Read More
Amazon certainly isn’t the first major corporation to arrive at the cannabis reform party, but it sure made one of the biggest entrances to-date when it publicly pledged to relax its drug testing policies and also to back federal legalization efforts. Which companies will be next?
Read More
Cannabis advocates, medical nonprofits and veterans groups are urging state governors to not shut off access to cannabis businesses.
Read More
Signs are emerging that dealmaking activity may be returning to cannabis, but it won’t be like the Wild West-style land grab days of before.
Read More
A male’s marijuana use appears to alter sperm prior to mating, causing offspring to develop distinct abnormalities in areas of the brain that help govern learning, memory, reward and mood, according to a Duke-led study conducted on rats.
Read More
The California Bureau of Cannabis Control on Thursday proposed emergency regulations that would require state-licensed cannabis businesses to display their unique Quick Response Code certificates in their store windows and ensure they have the digital barcodes handy when transporting cannabis.
Read More
Vaping remained popular among teens across the United States in 2019, according to a new report, and there were significant increases in vaping of marijuana by eighth, 10th and 12th graders.
Read More
A new UNC-Chapel Hill study published in Scientific Reports shows how a one-time exposure during early pregnancy to marijuana incredients known as cannabinoids (CBs)– both synthetic and natural – can cause growth issues in a developing embryo.
Read More
Public cannabis companies are having a bear of a time. Stock prices are plunging, lofty valuations are deflating, regulatory landscapes remain in flux, and now deals are coming off the table.
Read More
